Patent · US Expired

Crosslinked hemoglobin product comprising tetrameric and oligomeric hemoglobin units

US5770727A · kind A · utility

1Cited by
3References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 28, 1996
Grant dateJun 23, 1998
Priority date
Expiry dateJun 28, 2016

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P7/08
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A chemically modified, crosslinked hemoglobin product suitable for use as a hemoglobin based oxygen carrier comprises a mixture of hemoglobin species and consists essentially of about 40% tetrameric hemoglobin units of molecular weight about 64,000 daltons, up to 5% dimeric hemoglobin units of molecular weight about 32,000 daltons, and the balance oligomeric hemoglobin units of molecular weight up to about 60,000 daltons, the mixed product containing no polymeric hemoglobin species of molecular weight greater than 600,000 daltons. The product can be made directly by a crosslinking reaction under controlled conditions, without the need for separating therefrom high molecular weight species.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.